884 related articles for article (PubMed ID: 27036044)
81. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract][Full Text] [Related]
82. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
83. Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck.
Li X; Ottosson S; Wang S; Jernberg E; Boldrup L; Gu X; Nylander K; Li A
BMC Cancer; 2015 May; 15():342. PubMed ID: 25929687
[TBL] [Abstract][Full Text] [Related]
84. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
[TBL] [Abstract][Full Text] [Related]
85. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.
Lu WC; Liu CJ; Tu HF; Chung YT; Yang CC; Kao SY; Chang KW; Lin SC
Oncotarget; 2016 Aug; 7(35):57254-57267. PubMed ID: 27528032
[TBL] [Abstract][Full Text] [Related]
86. Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion.
Rossa C; Sommer G; Spolidorio LC; Rosenzweig SA; Watson DK; Kirkwood KL
PLoS One; 2012; 7(9):e45197. PubMed ID: 23028842
[TBL] [Abstract][Full Text] [Related]
87. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
[TBL] [Abstract][Full Text] [Related]
88. Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma.
Wang Z; Chen J; Zhang W; Zheng Y; Wang Z; Liu L; Wu H; Ye J; Zhang W; Qi B; Wu Y; Song X
Oncotarget; 2016 Feb; 7(5):6048-62. PubMed ID: 26755661
[TBL] [Abstract][Full Text] [Related]
89. miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.
Zhang M; Piao L; Datta J; Lang JC; Xie X; Teknos TN; Mapp AK; Pan Q
Mol Cancer Ther; 2015 Oct; 14(10):2313-20. PubMed ID: 26227488
[TBL] [Abstract][Full Text] [Related]
90. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Wang SS; Cen X; Liang XH; Tang YL
Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
[TBL] [Abstract][Full Text] [Related]
91. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract][Full Text] [Related]
92. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
Huang J; Ji EH; Zhao X; Cui L; Misuno K; Guo M; Huang Z; Chen X; Hu S
J Exp Clin Cancer Res; 2019 Mar; 38(1):138. PubMed ID: 30922366
[TBL] [Abstract][Full Text] [Related]
93. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
[TBL] [Abstract][Full Text] [Related]
94. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
95. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma.
León X; Bothe C; García J; Parreño M; Alcolea S; Quer M; Vila L; Camacho M
Oncotarget; 2015 Nov; 6(35):37398-409. PubMed ID: 26460957
[TBL] [Abstract][Full Text] [Related]
96. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.
Sun ZJ; Yu GT; Huang CF; Bu LL; Liu JF; Ma SR; Zhang WF; Liu B; Zhang L
Oncotarget; 2016 Mar; 7(10):11651-63. PubMed ID: 26872381
[TBL] [Abstract][Full Text] [Related]
97. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.
Chen Y; Zhao R; Zhao Q; Shao Y; Zhang S
Oncol Res; 2016; 24(3):153-60. PubMed ID: 27458096
[TBL] [Abstract][Full Text] [Related]
98. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
[TBL] [Abstract][Full Text] [Related]
99. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
[TBL] [Abstract][Full Text] [Related]
100. Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.
Xu J; Lu W; Zhang S; Zhu C; Ren T; Zhu T; Zhao H; Liu Y; Su J
Cancer Biol Ther; 2014 May; 15(5):612-22. PubMed ID: 24556606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]